Management of the migraine patient
Abstract
Migraine is among the most common disorders seen in office practice. Some epidemiologists believe it may occur in up to 25 percent of the general population. Pharmacologic treatment and behavior therapy, as well as a stable physician-patient relationship, are important factors in reducing the frequency and severity of recurrent head pain. Benefits of migraine therapy include improvements in the patient's overall health and sense of well-being.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.